{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:27:10Z","timestamp":1790332030339,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 104-2320-B-038 -054 -MY3"],"award-info":[{"award-number":["MOST 104-2320-B-038 -054 -MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taipei Medical University and Taipei Medical University Hospital","award":["TMU101-AE1-B32"],"award-info":[{"award-number":["TMU101-AE1-B32"]}]},{"name":"Taipei Medical University and Taipei Medical University Hospital","award":["103TMU-TMUH-13"],"award-info":[{"award-number":["103TMU-TMUH-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12929-016-0290-z","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T02:57:42Z","timestamp":1477018662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS"],"prefix":"10.1186","volume":"23","author":[{"given":"Cheng-Fu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuen-Haur","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Kun James","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"290_CR1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","volume":"10","author":"MS Forman","year":"2004","unstructured":"Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med. 2004;10:1055\u201363.","journal-title":"Nat Med"},{"key":"290_CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130\u20133.","journal-title":"Science"},{"key":"290_CR3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"290_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmb.2005.02.038","volume":"348","author":"YM Ayala","year":"2005","unstructured":"Ayala YM, Pantano S, D\u2019Ambrogio A, Buratti E, Brindisi A, Marchetti C, Romano M, Baralle FE. Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol. 2005;348:575\u201388.","journal-title":"J Mol Biol"},{"key":"290_CR5","doi-asserted-by":"crossref","first-page":"37572","DOI":"10.1074\/jbc.M505557200","volume":"280","author":"E Buratti","year":"2005","unstructured":"Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE. TDP-43 binds heterogeneous nuclear ribonucleoprotein A\/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem. 2005;280:37572\u201384.","journal-title":"J Biol Chem"},{"key":"290_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0888-7543(03)00214-3","volume":"83","author":"HY Wang","year":"2004","unstructured":"Wang HY, Wang IF, Bose J, Shen CK. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics. 2004;83:130\u20139.","journal-title":"Genomics"},{"key":"290_CR7","doi-asserted-by":"crossref","first-page":"36337","DOI":"10.1074\/jbc.M104236200","volume":"276","author":"E Buratti","year":"2001","unstructured":"Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001;276:36337\u201343.","journal-title":"J Biol Chem"},{"key":"290_CR8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416\u201338.","journal-title":"Neuron"},{"key":"290_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-007-0240-7","volume":"114","author":"M Mishra","year":"2007","unstructured":"Mishra M, Paunesku T, Woloschak GE, Siddique T, Zhu LJ, Lin S, Greco K, Bigio EH. Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol. 2007;114:81\u201394.","journal-title":"Acta Neuropathol"},{"key":"290_CR10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/ddn023","volume":"17","author":"AS Chen-Plotkin","year":"2008","unstructured":"Chen-Plotkin AS, Geser F, Plotkin JB, Clark CM, Kwong LK, Yuan W, Grossman M, Van Deerlin VM, Trojanowski JQ, Lee VM. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration. Hum Mol Genet. 2008;17:1349\u201362.","journal-title":"Hum Mol Genet"},{"key":"290_CR11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","volume":"15","author":"Z Berger","year":"2006","unstructured":"Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, O\u2019Kane CJ, Rubinsztein DC. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet. 2006;15:433\u201342.","journal-title":"Hum Mol Genet"},{"key":"290_CR12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","volume":"90","author":"B Ravikumar","year":"2010","unstructured":"Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, Underwood BR, Winslow AR, Rubinsztein DC. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90:1383\u2013435.","journal-title":"Physiol Rev"},{"key":"290_CR13","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1074\/jbc.M808064200","volume":"284","author":"SH Kim","year":"2009","unstructured":"Kim SH, Shi Y, Hanson KA, Williams LM, Sakasai R, Bowler MJ, Tibbetts RS. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. J Biol Chem. 2009;284:8083\u201392.","journal-title":"J Biol Chem"},{"key":"290_CR14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/jnr.22243","volume":"88","author":"M Urushitani","year":"2010","unstructured":"Urushitani M, Sato T, Bamba H, Hisa Y, Tooyama I. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J Neurosci Res. 2010;88:784\u201397.","journal-title":"J Neurosci Res"},{"key":"290_CR15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2009.11.055","volume":"469","author":"X Wang","year":"2010","unstructured":"Wang X, Fan H, Ying Z, Li B, Wang H, Wang G. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci Lett. 2010;469:112\u20136.","journal-title":"Neurosci Lett"},{"key":"290_CR16","doi-asserted-by":"crossref","first-page":"27416","DOI":"10.1074\/jbc.M109.031278","volume":"284","author":"A Caccamo","year":"2009","unstructured":"Caccamo A, Majumder S, Deng JJ, Bai Y, Thornton FB, Oddo S. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem. 2009;284:27416\u201324.","journal-title":"J Biol Chem"},{"key":"290_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1083\/jcb.200702115","volume":"179","author":"M Filimonenko","year":"2007","unstructured":"Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerod L, Fisher EM, Isaacs A, Brech A, Stenmark H, Simonsen A. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol. 2007;179:485\u2013500.","journal-title":"J Cell Biol"},{"key":"290_CR18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200908115","volume":"187","author":"JS Ju","year":"2009","unstructured":"Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol. 2009;187:875\u201388.","journal-title":"J Cell Biol"},{"key":"290_CR19","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1242\/jcs.136150","volume":"127","author":"CC Huang","year":"2014","unstructured":"Huang CC, Bose JK, Majumder P, Lee KH, Huang JT, Huang JK, Shen CK. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43. J Cell Sci. 2014;127:3024\u201338.","journal-title":"J Cell Sci"},{"key":"290_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12154-008-0003-5","volume":"1","author":"LM Ballou","year":"2008","unstructured":"Ballou LM, Lin RZ. Rapamycin and mTOR kinase inhibitors. J Chem Biol. 2008;1:27\u201336.","journal-title":"J Chem Biol"},{"key":"290_CR21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4161\/auto.6555","volume":"4","author":"S Diaz-Troya","year":"2008","unstructured":"Diaz-Troya S, Perez-Perez ME, Florencio FJ, Crespo JL. The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy. 2008;4:851\u201365.","journal-title":"Autophagy"},{"key":"290_CR22","doi-asserted-by":"crossref","first-page":"15024","DOI":"10.1073\/pnas.1206362109","volume":"109","author":"IF Wang","year":"2012","unstructured":"Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ, Shen CK. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A. 2012;109:15024\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/auto.7.4.14541","volume":"7","author":"X Zhang","year":"2011","unstructured":"Zhang X, Li L, Chen S, Yang D, Wang Y, Zhang X, Wang Z, Le W. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:412\u201325.","journal-title":"Autophagy"},{"key":"290_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12967-015-0450-z","volume":"13","author":"X Fan","year":"2015","unstructured":"Fan X, Wang J, Hou J, Lin C, Bensoussan A, Chang D, Liu J, Wang B. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK\/mTOR signaling pathway. J Transl Med. 2015;13:92.","journal-title":"J Transl Med"},{"key":"290_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2014.01.061","volume":"728","author":"MH Li","year":"2014","unstructured":"Li MH, Zhang YJ, Yu YH, Yang SH, Iqbal J, Mi QY, Li B, Wang ZM, Mao WX, Xie HG, Chen SL. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy. Eur J Pharmacol. 2014;728:67\u201376.","journal-title":"Eur J Pharmacol"},{"key":"290_CR26","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.lfs.2005.02.033","volume":"77","author":"X Wang","year":"2005","unstructured":"Wang X, Wang R, Xing D, Su H, Ma C, Ding Y, Du L. Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci. 2005;77:3058\u201367.","journal-title":"Life Sci"},{"key":"290_CR27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1248\/bpb.32.1433","volume":"32","author":"HA Jung","year":"2009","unstructured":"Jung HA, Min BS, Yokozawa T, Lee JH, Kim YS, Choi JS. Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol Pharm Bull. 2009;32:1433\u20138.","journal-title":"Biol Pharm Bull"},{"key":"290_CR28","doi-asserted-by":"crossref","first-page":"e0134142","DOI":"10.1371\/journal.pone.0134142","volume":"10","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wei W, Gaertig MA, Li S, Li XJ. Therapeutic effect of berberine on Huntington\u2019s disease transgenic mouse model. PLoS ONE. 2015;10:e0134142.","journal-title":"PLoS ONE"},{"key":"290_CR29","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","volume":"33","author":"SS Durairajan","year":"2012","unstructured":"Durairajan SS, Liu LF, Lu JH, Chen LL, Yuan Q, Chung SK, Huang L, Li XS, Huang JD, Li M. Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer\u2019s disease transgenic mouse model. Neurobiol Aging. 2012;33:2903\u201319.","journal-title":"Neurobiol Aging"},{"key":"290_CR30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pharep.2015.03.002","volume":"67","author":"T Ahmed","year":"2015","unstructured":"Ahmed T, Gilani AU, Abdollahi M, Daglia M, Nabavi SF, Nabavi SM. Berberine and neurodegeneration: A review of literature. Pharmacol Rep. 2015;67:970\u20139.","journal-title":"Pharmacol Rep"},{"key":"290_CR31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3892\/ijmm.2014.1656","volume":"33","author":"M Kim","year":"2014","unstructured":"Kim M, Cho KH, Shin MS, Lee JM, Cho HS, Kim CJ, Shin DH, Yang HJ. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson\u2019s disease. Int J Mol Med. 2014;33:870\u20138.","journal-title":"Int J Mol Med"},{"key":"290_CR32","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1074\/jbc.M800342200","volume":"283","author":"MJ Winton","year":"2008","unstructured":"Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem. 2008;283:13302\u20139.","journal-title":"J Biol Chem"},{"key":"290_CR33","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","volume":"18","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet. 2009;18:3353\u201364.","journal-title":"Hum Mol Genet"},{"key":"290_CR34","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","volume":"106","author":"YJ Zhang","year":"2009","unstructured":"Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes-Casey M, Ash P, Gass J, Rangachari V, Buratti E, Baralle F, Golde TE, Dickson DW, Petrucelli L. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A. 2009;106:7607\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.pathmechdis.2.010506.091842","volume":"3","author":"M Kundu","year":"2008","unstructured":"Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol. 2008;3:427\u201355.","journal-title":"Annu Rev Pathol"},{"key":"290_CR36","doi-asserted-by":"crossref","first-page":"13830","DOI":"10.3390\/ijms131113830","volume":"13","author":"K Maiese","year":"2012","unstructured":"Maiese K, Chong ZZ, Wang S, Shang YC. Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade. Int J Mol Sci. 2012;13:13830\u201366.","journal-title":"Int J Mol Sci"},{"key":"290_CR37","first-page":"161020","volume":"2015","author":"S Fan","year":"2015","unstructured":"Fan S, Zhang B, Luan P, Gu B, Wan Q, Huang X, Liao W, Liu J. PI3K\/AKT\/mTOR\/p70S6K Pathway Is Involved in Abeta25-35-Induced Autophagy. Biomed Res Int. 2015;2015:161020.","journal-title":"Biomed Res Int"},{"key":"290_CR38","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1073\/pnas.79.6.1889","volume":"79","author":"PO Seglen","year":"1982","unstructured":"Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic\/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1982;79:1889\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR39","doi-asserted-by":"crossref","first-page":"22123","DOI":"10.1074\/jbc.274.32.22123","volume":"274","author":"GN DeMartino","year":"1999","unstructured":"DeMartino GN, Slaughter CA. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem. 1999;274:22123\u20136.","journal-title":"J Biol Chem"},{"key":"290_CR40","doi-asserted-by":"crossref","first-page":"44441","DOI":"10.1074\/jbc.M111.237115","volume":"286","author":"JK Bose","year":"2011","unstructured":"Bose JK, Huang CC, Shen CK. Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem. 2011;286:44441\u20138.","journal-title":"J Biol Chem"},{"key":"290_CR41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O\u2019Kane CJ, Rubinsztein DC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36:585\u201395.","journal-title":"Nat Genet"},{"key":"290_CR42","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010;285:13107\u201320.","journal-title":"J Biol Chem"},{"key":"290_CR43","doi-asserted-by":"crossref","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","volume":"5","author":"L Crews","year":"2010","unstructured":"Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS ONE. 2010;5:e9313.","journal-title":"PLoS ONE"},{"key":"290_CR44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","volume":"12","author":"J Bove","year":"2011","unstructured":"Bove J, Martinez-Vicente M, Vila M. Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev. 2011;12:437\u201352.","journal-title":"Nat Rev"},{"key":"290_CR45","doi-asserted-by":"crossref","first-page":"e4201","DOI":"10.1371\/journal.pone.0004201","volume":"4","author":"D Ling","year":"2009","unstructured":"Ling D, Song HJ, Garza D, Neufeld TP, Salvaterra PM. Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS ONE. 2009;4:e4201.","journal-title":"PLoS ONE"},{"key":"290_CR46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/187153008784534330","volume":"8","author":"J Yin","year":"2008","unstructured":"Yin J, Zhang H, Ye J. Traditional chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets. 2008;8:99\u2013111.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"290_CR47","doi-asserted-by":"crossref","unstructured":"Berberine. Altern Med Rev 2000;5:175\u2013177.","DOI":"10.1034\/j.1600-065X.2000.17715.x"},{"key":"290_CR48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.phymed.2009.05.021","volume":"16","author":"PK Prabhakar","year":"2009","unstructured":"Prabhakar PK, Doble M. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine. 2009;16:1119\u201326.","journal-title":"Phytomedicine"},{"key":"290_CR49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/ern.09.40","volume":"9","author":"SK Kulkarni","year":"2009","unstructured":"Kulkarni SK. Dhir A: sigma-1 receptors in major depression and anxiety. Expert Rev Neurother. 2009;9:1021\u201334.","journal-title":"Expert Rev Neurother"},{"key":"290_CR50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2008.05.043","volume":"589","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni SK, Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol. 2008;589:163\u201372.","journal-title":"Eur J Pharmacol"},{"key":"290_CR51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00002826-200011000-00005","volume":"23","author":"JM Rabey","year":"2000","unstructured":"Rabey JM, Sagi I, Huberman M, Melamed E, Korczyn A, Giladi N, Inzelberg R, Djaldetti R, Klein C, Berecz G. Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa. Clin Neuropharmacol. 2000;23:324\u201330.","journal-title":"Clin Neuropharmacol"},{"key":"290_CR52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2001-10874","volume":"67","author":"LD Kong","year":"2001","unstructured":"Kong LD, Cheng CH, Tan RX. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med. 2001;67:74\u20136.","journal-title":"Planta Med"},{"key":"290_CR53","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jcb.22198","volume":"107","author":"JM Hur","year":"2009","unstructured":"Hur JM, Hyun MS, Lim SY, Lee WY, Kim D. The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J Cell Biochem. 2009;107:955\u201364.","journal-title":"J Cell Biochem"},{"key":"290_CR54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2011.10.019","volume":"12","author":"JH Chen","year":"2012","unstructured":"Chen JH, Huang SM, Tan TW, Lin HY, Chen PY, Yeh WL, Chou SC, Tsai CF, Wei IH, Lu DY. Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase\/AKT and NF-E2-related factor-2 signaling pathway in astrocytes. Int Immunopharmacol. 2012;12:94\u2013100.","journal-title":"Int Immunopharmacol"},{"key":"290_CR55","first-page":"159","volume":"200","author":"SS Lu","year":"2009","unstructured":"Lu SS, Yu YL, Zhu HJ, Liu XD, Liu L, Liu YW, Wang P, Xie L, Wang GJ. Berberine promotes glucagon-like peptide-1 (7\u201336) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol. 2009;200:159\u201365.","journal-title":"J Endocrinol"},{"key":"290_CR56","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bcp.2009.11.017","volume":"79","author":"Y Yu","year":"2010","unstructured":"Yu Y, Liu L, Wang X, Liu X, Liu X, Xie L, Wang G. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol. 2010;79:1000\u20136.","journal-title":"Biochem Pharmacol"},{"key":"290_CR57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2012.03.065","volume":"1459","author":"X Zhang","year":"2012","unstructured":"Zhang X, Zhang X, Wang C, Li Y, Dong L, Cui L, Wang L, Liu Z, Qiao H, Zhu C, Xing Y, Cao X, Ji Y, Zhao K. Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-kappaB expression, ameliorated BBB permeability. Brain Res. 2012;1459:61\u201370.","journal-title":"Brain Res"},{"key":"290_CR58","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.3390\/molecules16086732","volume":"16","author":"HF Ji","year":"2011","unstructured":"Ji HF, Shen L. Berberine: a potential multipotent natural product to combat Alzheimer\u2019s disease. Molecules. 2011;16:6732\u201340.","journal-title":"Molecules"},{"key":"290_CR59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","volume":"203","author":"T Perry","year":"2007","unstructured":"Perry T, Holloway HW, Weerasuriya A, Mouton PR, Duffy K, Mattison JA, Greig NH. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp Neurol. 2007;203:293\u2013301.","journal-title":"Exp Neurol"},{"key":"290_CR60","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1128\/MCB.19.8.5800","volume":"19","author":"SG Kennedy","year":"1999","unstructured":"Kennedy SG, Kandel ES, Cross TK, Hay N. Akt\/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol. 1999;19:5800\u201310.","journal-title":"Mol Cell Biol"},{"key":"290_CR61","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","volume":"106","author":"Y Li","year":"2009","unstructured":"Li Y, Perry T, Kindy MS, Harvey BK, Tweedie D, Holloway HW, Powers K, Shen H, Egan JM, Sambamurti K, Brossi A, Lahiri DK, Mattson MP, Hoffer BJ, Wang Y, Greig NH. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A. 2009;106:1285\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"290_CR62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2741\/1197","volume":"9","author":"M Dragunow","year":"2004","unstructured":"Dragunow M. CREB and neurodegeneration. Front Biosci. 2004;9:100\u20133.","journal-title":"Front Biosci"},{"key":"290_CR63","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.bmc.2009.12.035","volume":"18","author":"L Huang","year":"2010","unstructured":"Huang L, Shi A, He F, Li X. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Bioorg Med Chem. 2010;18:1244\u201351.","journal-title":"Bioorg Med Chem"},{"key":"290_CR64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12272-013-0051-4","volume":"36","author":"KS Shin","year":"2013","unstructured":"Shin KS, Choi HS, Zhao TT, Suh KH, Kwon IH, Choi SO, Lee MK. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Arch Pharm Res. 2013;36:759\u201367.","journal-title":"Arch Pharm Res"},{"key":"290_CR65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2010.09.038","volume":"486","author":"IH Kwon","year":"2010","unstructured":"Kwon IH, Choi HS, Shin KS, Lee BK, Lee CK, Hwang BY, Lim SC, Lee MK. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson\u2019s disease. Neurosci Lett. 2010;486:29\u201333.","journal-title":"Neurosci Lett"},{"key":"290_CR66","doi-asserted-by":"crossref","first-page":"e107129","DOI":"10.1371\/journal.pone.0107129","volume":"9","author":"K Kysenius","year":"2014","unstructured":"Kysenius K, Brunello CA, Huttunen HJ. Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury. PLoS ONE. 2014;9:e107129.","journal-title":"PLoS ONE"},{"key":"290_CR67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27\u201342.","journal-title":"Cell"},{"key":"290_CR68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1211\/jpp.61.07.0001","volume":"61","author":"M Ye","year":"2009","unstructured":"Ye M, Fu S, Pi R, He F. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. J Pharm Pharmacol. 2009;61:831\u20137.","journal-title":"J Pharm Pharmacol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-016-0290-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T02:58:48Z","timestamp":1718852328000},"score":1,"resource":{"primary":{"URL":"http:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-016-0290-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1186\/s12929-016-0290-z","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]},"article-number":"72"}}